Encodamers: Unnatural peptide oligomers encoded in RNA

Chemistry and Biology

Volumn 10, Issue 11, 2003, Pages 1043-1050

  Frankel, Adam ^a   Millward, Steven W ^a   Roberts, Richard W ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345531149     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2003.11.004     Document Type: Article

References (47)

1. Weiss G.A., Watanabe C.K., Zhong A., Goddard A., Sidhu S.S. Rapid mapping of protein functional epitopes by combinatorial alanine scanning. Proc. Natl. Acad. Sci. USA. 97:2000;8950-8954.
2. Takahashi T.T., Austin R.J., Roberts R.W. mRNA display. ligand discovery, interaction analysis and beyond Trends Biochem. Sci. 28:2003;159-165.
3. Aina O.H., Sroka T.C., Chen M.L., Lam K.S. Therapeutic cancer targeting peptides. Biopolymers. 66:2002;184-199.
4. Burkoth T.S., Beausoleil E., Kaur S., Tang D., Cohen F.E., Zuckermann R.N. Toward the synthesis of artificial proteins. the discovery of an amphiphilic helical peptoid assembly Chem. Biol. 9:2002;647-654.
5. Mattheakis L.C., Bhatt R.R., Dower W.J. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc. Natl. Acad. Sci. USA. 91:1994;9022-9026.
6. Hanes J., Pluckthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc. Natl. Acad. Sci. USA. 94:1997;4937-4942.
7. Merryman C., Weinstein E., Wnuk S.F., Bartel D.P. A bifunctional tRNA for in vitro selection. Chem. Biol. 9:2002;741-746.
8. Roberts R.W., Szostak J.W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. USA. 94:1997;12297-12302.
9. Frankel A., Li S., Starck S.R., Roberts R.W. Unnatural RNA display libraries. Curr. Opin. Struct. Biol. 13:2003;506-512.
10. Li S., Millward S., Roberts R. In vitro selection of mRNA display libraries containing an unnatural amino acid. J. Am. Chem. Soc. 124:2002;9972-9973.
11. Frankel A., Roberts R.W. In vitro selection for sense codon suppression. RNA. 9:2003;780-786.
12. Li S., Roberts R.W. A novel strategy for in vitro selection of Peptide-drug conjugates. Chem. Biol. 10:2003;233-239.
13. Hohsaka T., Ashizuka Y., Sasaki H., Murakami H., Sisido M. Incorporation of two different nonnatural amino acids independently into a single protein through extension of the genetic code. J. Am. Chem. Soc. 121:1999;12194-12195.
14. Forster A.C., Tan Z., Nalam M.N., Lin H., Qu H., Cornish V.W., Blacklow S.C. Programming peptidomimetic syntheses by translating genetic codes designed de novo. Proc. Natl. Acad. Sci. USA. 100:2003;6353-6357.
15. Cane D.E., Walsh C.T., Khosla C. Harnessing the biosynthetic code. combinations, permutations, and mutations Science. 282:1998;63-68.
16. Walsh C.T., Chen H., Keating T.A., Hubbard B.K., Losey H.C., Luo L., Marshall C.G., Miller D.A., Patel H.M. Tailoring enzymes that modify nonribosomal peptides during and after chain elongation on NRPS assembly lines. Curr. Opin. Chem. Biol. 5:2001;525-534.
17. Lipinski C.A., Lombardo F., Dominy B.W., Feeny P.J. Experimental and computational approaches to estimate the solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:1997;3-25.
18. Owens J. Chris Lipinski discusses life and chemistry after the Rule of Five. Drug Discov. Today. 8:2003;12-16.
19. Goodman L.S., Gilman A., Hardman J.G., Gilman A.G., Limbird L.E. Goodman & Gilman's Pharmacological Basis of Therapeutics. Ninth Edition:1996;McGraw- Hill, New York.
20. Fliri H., Baumann G., Enz A., Kallen J., Luyten M., Mikol V., Movva R., Quesniaux V., Schreier M., Walkinshaw M., et al. Cyclosporins. Structure-activity relationships. Ann. N Y Acad. Sci. 696:1993;47-53.
21. Fahr A. Cyclosporin clinical pharmacokinetics. Clin. Pharmacokinet. 24:1993;472-495.
22. Christians U., Sewing K.F. Cyclosporin metabolism in transplant patients. Pharmacol. Ther. 57:1993;291-345.
23. Jackson R.J., Napthine S., Brierley I. Development of a tRNA-dependent in vitro translation system. RNA. 7:2001;765-773.
24. Nirenberg M.W., Matthaei J.H. The dependence of cell-free protein synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides. Proc. Natl. Acad. Sci. USA. 47:1961;1588-1602.
25. Simon R.J., Kania R.S., Zuckermann R.N., Huebner V.D., Jewell D.A., Banville S., Ng S., Wang L., Rosenberg S., Marlowe C.K., et al. Peptoids. a modular approach to drug discovery Proc. Natl. Acad. Sci. USA. 89:1992;9367-9371.
26. Miller S.M., Simon R.J., Ng S., Zuckermann R.N., Kerr J.M., Moos W.H. Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide and peptoid oligomiers. Drug Dev. Res. 35:1995;20-32.
27. Kirshenbaum K., Barron A.E., Goldsmith R.A., Armand P., Bradley E.K., Truong K.T., Dill K.A., Cohen F.E., Zuckermann R.N. Sequence-specific polypeptoids. a diverse family of heteropolymers with stable secondary structure Proc. Natl. Acad. Sci. USA. 95:1998;4303-4308.
28. Nguyen J.T., Turck C.W., Cohen F.E., Zuckermann R.N., Lim W.A. Exploiting the basis of proline recognition by SH3 and WW domains. design of N-substituted inhibitors Science. 282:1998;2088-2092.
29. Nguyen J.T., Porter M., Amoui M., Miller W.T., Zuckermann R.N., Lim W.A. Improving SH3 domain ligand selectivity using a nonnatural scaffold. Chem. Biol. 7:2000;463-473.
30. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake. peptoid molecular transporters Proc. Natl. Acad. Sci. USA. 97:2000;13003-13008.
31. Cornish V.W., Mendel D., Schultz P.G. Probing protein structure and function with an expanded genetic code. Angew. Chem. Int. Ed. Engl. 34:1995;621-633.
32. Gilmore M.A., Steward L.E., Chamberlin A.R. Incorporation of noncoded amino acids by in vitro protein biosynthesis. Top. Curr. Chem. 202:1999;77-99.
33. van Hest J.C.M., Tirrell D.A. Protein-based materials, towards a new level of structural control. Chem. Commun. 19:2001;1897-1904.
34. Roesser J.R., Chorghade M.S., Hecht S.M. Ribosome-catalyzed formation of an abnormal peptide analogue. Biochemistry. 25:1986;6361-6365.
35. Bain J.D., Wacjer D.A., Kuo E.E., Chamberlin A.R., Diala E.S. Site-specific incorporation of non-natural residues into peptides. effect of residue structure on suppression and translation efficiencies Tetrahedron. 47:1991;2389-2400.
36. Ellman J.A., Mendel D., Schultz P.G. Site-specific incorporation of novel backbone structures into proteins. Science. 255:1992;197-200.
37. Mendel D., Ellman J., Schultz P.G. Protein biosynthesis with conformationally restricted amino acids. J. Am. Chem. Soc. 115:1993;4359-4360.
38. Koh J.T., Cornish V.W., Schultz P.G. An experimental approach to evaluating the role of backbone interactions in proteins using unnatural amino acid mutagenesis. Biochemistry. 36:1997;11314-11322.
39. Killian J.A., Van Cleve M.D., Shayo Y.F., Hecht S.M. Ribosome-mediated incorporation of hydrazinophenylalanine into modified peptide and protein analogues. J. Am. Chem. Soc. 120:1998;3032-3042.
40. Eisenhauer B.M., Hecht S.M. Site-specific incorporation of (aminooxy)acetic acid into proteins. Biochemistry. 41:2002;11472-11478.
41. Shimizu Y., Inoue A., Tomari Y., Suzuki T., Yokogawa T., Nishikawa K., Ueda T. Cell-free translation reconstituted with purified components. Nat. Biotechnol. 19:2001;751-755.
42. Forster A.C., Weissbach H., Blacklow S.C. A simplified reconstitution of mRNA-directed peptide synthesis. activity of the epsilon enhancer and an unnatural amino acid Anal. Biochem. 297:2001;60-70.
43. Ellman J., Mendel D., Anthony-Cahill S., Noren C.J., Schultz P.G. Biosynthetic method for introducing unnatural amino acids site-specifically into proteins. Methods Enzymol. 202:1991;301-336.
44. Gallivan J.P., Lester H.A., Dougherty D.A. Site-specific incorporation of biotinylated amino acids to identify surface-exposed residues in integral membrane proteins. Chem. Biol. 4:1997;739-749.
45. Saks M.E., Sampson J.R., Nowak M.W., Kearney P.C., Du F., Abelson J.N., Lester H.A., Dougherty D.A. An engineered Tetrahymena tRNAGln for in vivo incorporation of unnatural amino acids into proteins by nonsense suppression. J. Biol. Chem. 271:1996;23169-23175.
46. Pestova T.V., Hellen C.U. Preparation and activity of synthetic unmodified mammalian tRNAi(Met) in initiation of translation in vitro. RNA. 7:2001;1496-1505.
47. Schagger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.